| dc.contributor.author | Canturk, F | |
| dc.contributor.author | Canturk, T | |
| dc.contributor.author | Aydin, F | |
| dc.contributor.author | Karagoz, F | |
| dc.contributor.author | Senturk, N | |
| dc.contributor.author | Turanli, AY | |
| dc.date.accessioned | 2020-06-21T15:43:16Z | |
| dc.date.available | 2020-06-21T15:43:16Z | |
| dc.date.issued | 2004 | |
| dc.identifier.issn | 0011-4162 | |
| dc.identifier.issn | 2326-6929 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/21561 | |
| dc.description | WOS: 000220247700009 | en_US |
| dc.description | PubMed: 15074349 | en_US |
| dc.description.abstract | It is well-known that local and systemic side effects due to intralesional corticosteroid injections are common. We report the case of a 28-year-old woman with cutaneous linear atrophy along the abductor pollicis longus tendon, which appeared after an injection of intralesional corticosteroid in the treatment of do Quervain tendonitis. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Quadrant Healthcom Inc | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Cutaneous linear atrophy following intralesional corticosteroid injection in the treatment of tendonitis | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 73 | en_US |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.startpage | 197 | en_US |
| dc.identifier.endpage | 198 | en_US |
| dc.relation.journal | Cutis | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
